News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
869,038 Results
Type
Article (87874)
Company Profile (825)
Press Release (780324)
Multimedia
Podcasts (190)
Webinars (28)
Section
Business (233218)
Career Advice (4144)
Deals (39863)
Drug Delivery (145)
Drug Development (91393)
Employer Resources (203)
FDA (18376)
Job Trends (17417)
News (397824)
Policy (39958)
Tag
Academia (3006)
Academic (2)
Accelerated approval (31)
Adcomms (36)
Allergies (142)
Alliances (56981)
ALS (180)
Alzheimer's disease (1782)
Antibody-drug conjugate (ADC) (333)
Approvals (18540)
Artificial intelligence (610)
Autoimmune disease (154)
Automation (34)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (198)
Biotechnology (489)
Bladder cancer (158)
Brain cancer (64)
Breast cancer (644)
Cancer (4899)
Cardiovascular disease (433)
Career advice (3566)
Career pathing (40)
CAR-T (300)
CDC (59)
Celiac Disease (1)
Cell therapy (811)
Cervical cancer (37)
Clinical research (76868)
Collaboration (1737)
Company closure (5)
Compensation (1120)
Complete response letters (70)
COVID-19 (2986)
CRISPR (96)
C-suite (821)
Cystic fibrosis (154)
Data (6123)
Decentralized trials (2)
Denatured (70)
Depression (143)
Diabetes (523)
Diagnostics (7207)
Digital health (44)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (292)
Drug pricing (217)
Drug shortages (36)
Duchenne muscular dystrophy (232)
Earnings (100021)
Editorial (60)
Employer branding (25)
Employer resources (173)
Events (134933)
Executive appointments (1023)
FDA (21429)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (9)
Frontotemporal dementia (24)
Funding (1523)
Gene editing (210)
Generative AI (62)
Gene therapy (657)
GLP-1 (1107)
Government (5431)
Grass and pollen (8)
Guidances (382)
Healthcare (20941)
HIV (58)
Huntington's disease (48)
IgA nephropathy (86)
Immunology and inflammation (286)
Immuno-oncology (51)
Indications (82)
Infectious disease (3267)
Inflammatory bowel disease (201)
Inflation Reduction Act (17)
Influenza (117)
Intellectual property (235)
Interviews (816)
IPO (17952)
IRA (60)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (89)
Layoffs (656)
Leadership (39)
Legal (10156)
Liver cancer (97)
Longevity (14)
Lung cancer (668)
Lymphoma (368)
Machine learning (42)
Management (66)
Manufacturing (812)
MASH (171)
Medical device (14999)
Medtech (15043)
Mergers & acquisitions (22944)
Metabolic disorders (1358)
Multiple sclerosis (157)
NASH (23)
Neurodegenerative disease (339)
Neuropsychiatric disorders (92)
Neuroscience (3060)
NextGen: Class of 2026 (7706)
Non-profit (5107)
Now hiring (62)
Obesity (653)
Opinion (330)
Ovarian cancer (161)
Pain (198)
Pancreatic cancer (224)
Parkinson's disease (288)
Partnered (38)
Patents (487)
Patient recruitment (452)
Peanut (60)
People (66801)
Pharmaceutical (145)
Pharmacy benefit managers (31)
Phase I (23759)
Phase II (33352)
Phase III (25143)
Pipeline (4617)
Policy (328)
Postmarket research (3554)
Preclinical (10679)
Press Release (72)
Prostate cancer (237)
Psychedelics (53)
Radiopharmaceuticals (298)
Rare diseases (861)
Real estate (7437)
Recruiting (80)
Regulatory (28832)
Reports (65)
Research institute (2720)
Resumes & cover letters (651)
Rett syndrome (27)
RNA editing (19)
RSV (82)
Schizophrenia (157)
Series A (253)
Series B (192)
Service/supplier (30)
Sickle cell disease (103)
Special edition (27)
Spinal muscular atrophy (175)
Sponsored (47)
Startups (4333)
State (2)
Stomach cancer (20)
Supply chain (111)
Tariffs (98)
The Weekly (118)
Vaccines (1124)
Venture capital (91)
Weight loss (449)
Women's health (84)
Worklife (21)
Date
Today (162)
Last 7 days (948)
Last 30 days (2264)
Last 365 days (33335)
2026 (1351)
2025 (33226)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (87)
Alaska (7)
Arizona (338)
Arkansas (14)
Asia (51472)
Australia (9033)
California (11285)
Canada (3250)
China (1125)
Colorado (474)
Connecticut (490)
Delaware (339)
Europe (118273)
Florida (1652)
Georgia (359)
Hawaii (3)
Idaho (68)
Illinois (937)
India (64)
Indiana (532)
Iowa (23)
Japan (412)
Kansas (132)
Kentucky (42)
Louisiana (29)
Maine (82)
Maryland (1437)
Massachusetts (8355)
Michigan (348)
Minnesota (647)
Mississippi (6)
Missouri (137)
Montana (35)
Nebraska (28)
Nevada (122)
New Hampshire (84)
New Jersey (3056)
New Mexico (33)
New York (2994)
North Carolina (1580)
North Dakota (10)
Northern California (5378)
Ohio (344)
Oklahoma (22)
Oregon (54)
Pennsylvania (2264)
Puerto Rico (20)
Rhode Island (49)
South America (1656)
South Carolina (62)
South Dakota (1)
Southern California (4343)
Tennessee (172)
Texas (1782)
United States (40851)
Utah (338)
Vermont (1)
Virginia (281)
Washington D.C. (85)
Washington State (948)
West Virginia (4)
Wisconsin (122)
Wyoming (2)
There are 869,038 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
obesity
Novartis Doesn’t Have a GLP-1. They Don’t Miss It In a World Of Me-Toos
Speaking to
BioSpace
at the J.P. Morgan Healthcare Conference, Novartis’ chief dealmaker Ronny Gal explains why the Swiss pharma hasn’t acquired a GLP-1, and why it probably won’t.
January 13, 2026
·
3 min read
·
Annalee Armstrong
Synexa Life Sciences
Deals
JPM26: Attendees Wonder, Where’s Our Big M&A Deal?
There hasn’t been a headline-stealing deal at J.P. Morgan yet. Nevertheless, the mood is positive amid green shoots and a flurry of dealmaking to end 2025.
January 13, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
Meloxicam Market Surpassed USD 12.34 Billion in 2032 Amid Rising Arthritis and Chronic Pain Cases
January 13, 2026
·
1 min read
Press Releases
Botox Market Size to worth US$ 12.57 Billion by 2032, Coherent Market Insights
January 13, 2026
·
1 min read
Events
JPM26: Confident Merck Sees Growth Through Keytruda Loss of Exclusivity
Merck CEO Rob Davis expressed high confidence during the company’s J.P. Morgan presentation on Monday, revealing that the company is open to deals in the range of “multi tens of billions of dollars.”
January 13, 2026
·
1 min read
·
Heather McKenzie
Policy
Acadia CEO Bands With Peers To Lobby Against MFN Drug Pricing for Small Biotech
Acadia Pharma’s Catherine Owen Adams has formed a group of small- to mid-cap biotechs to advocate against a ‘peanut butter blanket’ approach to drug pricing for small companies.
January 13, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
January 13, 2026
·
1 min read
Press Releases
Surescripts and GoodRx Partner to Advance Patient Price Transparency
January 13, 2026
·
7 min read
Press Releases
Zai Lab Highlights Strategic Priorities and Global Pipeline Progress at 44th Annual J.P. Morgan Healthcare Conference
January 13, 2026
·
8 min read
1 of 86,904
Next
